96 related articles for article (PubMed ID: 16951156)
1. Analysis of genetic alterations and clonal proliferation in children treated for acute lymphocytic leukemia.
Kendall HE; Vacek PM; Rivers JL; Rice SC; Messier TL; Finette BA
Cancer Res; 2006 Sep; 66(17):8455-61. PubMed ID: 16951156
[TBL] [Abstract][Full Text] [Related]
2. Analysis of microsatellite instability in children treated for acute lymphocytic leukemia with elevated HPRT mutant frequencies.
Kendall HE; Vacek PM; Finette BA
Mutagenesis; 2004 Sep; 19(5):409-12. PubMed ID: 15388815
[TBL] [Abstract][Full Text] [Related]
3. Genotoxicity of therapeutic intervention in children with acute lymphocytic leukemia.
Rice SC; Vacek P; Homans AH; Messier T; Rivers J; Kendall H; Finette BA
Cancer Res; 2004 Jul; 64(13):4464-71. PubMed ID: 15231655
[TBL] [Abstract][Full Text] [Related]
4. V(D)J recombinase-mediated HPRT mutations in peripheral blood lymphocytes of normal children.
Finette BA; Poseno T; Albertini RJ
Cancer Res; 1996 Mar; 56(6):1405-12. PubMed ID: 8640832
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of HPRT mutant frequency in children with cancer.
Rice SC; Vacek PM; Homans AH; Kendall H; Rivers J; Messier T; Finette BA
Environ Mol Mutagen; 2003; 42(1):44-9. PubMed ID: 12874812
[TBL] [Abstract][Full Text] [Related]
6. Association among somatic HPRT mutant frequency, peripheral blood T-lymphocyte clonality, and serologic parameters of disease activity in children with juvenile onset dermatomyositis.
Abramson LS; Albertini RJ; Pachman LM; Finette BA
Clin Immunol; 1999 Apr; 91(1):61-7. PubMed ID: 10219255
[TBL] [Abstract][Full Text] [Related]
7. A prospective study of hprt mutant and mutation frequencies in treated cancer patients.
Caggana M; Liber HL; Coleman CN; Mauch P; Clark JR; Kelsey KT
Cancer Epidemiol Biomarkers Prev; 1992; 1(7):573-80. PubMed ID: 1302570
[TBL] [Abstract][Full Text] [Related]
8. Prospective study of mutant frequencies at the hprt and T-cell receptor gene loci in pediatric cancer patients during chemotherapy.
Sawada M; Kubota M; Lin YW; Watanabe K; Koishi S; Usami I; Akiyama Y; Matsumura T; Furusho K
Cancer Epidemiol Biomarkers Prev; 1998 Aug; 7(8):711-7. PubMed ID: 9718224
[TBL] [Abstract][Full Text] [Related]
9. Gestational age and gender-specific in utero V(D)J recombinase-mediated deletions.
Yoshioka M; O'Neill JP; Vacek PM; Finette BA
Cancer Res; 2001 Apr; 61(8):3432-8. PubMed ID: 11309304
[TBL] [Abstract][Full Text] [Related]
10. Analysis of mutagenic V(D)J recombinase mediated mutations at the HPRT locus as an in vivo model for studying rearrangements with leukemogenic potential in children.
Finette BA
DNA Repair (Amst); 2006 Sep; 5(9-10):1049-64. PubMed ID: 16807138
[TBL] [Abstract][Full Text] [Related]
11. Increased hprt mutant frequencies in Brazilian children accidentally exposed to ionizing radiation.
Saddi V; Curry J; Nohturfft A; Kusser W; Glickman BW
Environ Mol Mutagen; 1996; 28(3):267-75. PubMed ID: 8908186
[TBL] [Abstract][Full Text] [Related]
12. Selection of hprt mutant T cells as surrogates for dividing cells reveals a restricted T cell receptor BV repertoire in insulin-dependent diabetes mellitus.
Falta MT; Magin GK; Allegretta M; Steinman L; Atkinson MA; Brostoff SW; Albertini RJ
Clin Immunol; 1999 Mar; 90(3):340-51. PubMed ID: 10075863
[TBL] [Abstract][Full Text] [Related]
13. The L84F polymorphism in the O6-Methylguanine-DNA-Methyltransferase (MGMT) gene is associated with increased hypoxanthine phosphoribosyltransferase (HPRT) mutant frequency in lymphocytes of tobacco smokers.
Hill CE; Wickliffe JK; Guerin AT; Kinslow CJ; Wolfe KJ; Ammenheuser MM; Abdel-Rahman SZ
Pharmacogenet Genomics; 2007 Sep; 17(9):743-53. PubMed ID: 17700363
[TBL] [Abstract][Full Text] [Related]
14. Gene mutations with characteristic deletions in cord blood T lymphocytes associated with passive maternal exposure to tobacco smoke.
Finette BA; O'Neill JP; Vacek PM; Albertini RJ
Nat Med; 1998 Oct; 4(10):1144-51. PubMed ID: 9771747
[TBL] [Abstract][Full Text] [Related]
15. Emergence of genetic instability in children treated for leukemia.
Finette BA; Homans AC; Albertini RJ
Science; 2000 Apr; 288(5465):514-7. PubMed ID: 10775110
[TBL] [Abstract][Full Text] [Related]
16. Somatic mutations at T-cell antigen receptor and glycophorin A loci in pediatric leukemia patients following chemotherapy: comparison with HPRT locus mutation.
Hirota H; Kubota M; Adachi S; Okuda A; Lin YW; Bessho R; Wakazono Y; Matsubara K; Kuwakado K; Akiyama Y
Mutat Res; 1994 Sep; 315(2):95-103. PubMed ID: 7521002
[TBL] [Abstract][Full Text] [Related]
17. A comparison of somatic mutational spectra in healthy study populations from Russia, Sweden and USA.
Noori P; Hou S; Jones IM; Thomas CB; Lambert B
Carcinogenesis; 2005 Jun; 26(6):1138-51. PubMed ID: 15731167
[TBL] [Abstract][Full Text] [Related]
18. Increased mutant frequencies in the HPRT gene locus of leukemia HL-60 cells treated with succinylacetone.
Zheng KC; Yalowich JC; Kagan VE; Keohavong P
Cell Biol Toxicol; 2006 Sep; 22(5):361-70. PubMed ID: 16838078
[TBL] [Abstract][Full Text] [Related]
19. Identification of a new single-nucleotide mutation on the hypoxanthine-guanine phosphoribosyltransferase gene from 983 cases with gout in Taiwan.
Wu CH; Lai HM; Yang MC; Liaw CC; Chang SJ; Ko YC; Chen CJ
J Rheumatol; 2007 Apr; 34(4):794-7. PubMed ID: 17309125
[TBL] [Abstract][Full Text] [Related]
20. Distinct mechanisms lead to HPRT gene mutations in leukemic cells.
Lin YW; Perkins JJ; Zhang Z; Aplan PD
Genes Chromosomes Cancer; 2004 Apr; 39(4):311-23. PubMed ID: 14978792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
